-
Multiple Myeloma
1166
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-05-24 20:00:00
Learn the what, when, and how of multimodal disease assessment in the hematopathology lab for your patients with myeloma.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Non-Small Cell Lung Cancer
3004986
us
1
0.5
9
0.5
0.5
Roundtable
0
1
General Surgery2023-05-03 20:00:00
The complexity of treatment has increased dramatically; how effectively are you communicating with your patients?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Acute Leukemia
5005273
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-04-30 20:00:00
Do you understand the role of non-targetable driver mutations in the management of acute myeloid leukemia (AML)?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Biologic Therapy
5000033
global
1
0.75
9
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-04-27 20:00:00
How much do you know about antibody-drug conjugates (ADCs) for solid tumor management?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Non-Small Cell Lung Cancer
3004986
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-04-27 20:00:00
KRAS G12C-mutated NSCLC: do you know best practices for patient care?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Lung Cancer
5000186
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-04-23 20:00:00
Do you know how to personalize care for lung cancer patients with EGFR exon 20 mutations?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Multiple Myeloma
1166
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-05-24 20:00:00
Learn the what, when, and how of multimodal disease assessment in the hematopathology lab for your patients with myeloma.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Skin and Soft Tissue Infection
3029299
global
1
1.0
9
1.0
1.0
Journal Article
0
1
Infectious Diseases2023-05-17 20:00:00
A case series of Francisella tularensis-related prosthetic joint infection supports surgical treatment with long-term antibiotics.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Tropical Diseases
5005294
global
1
1.0
9
1.0
1.0
Journal Article
0
1
Infectious Diseases2023-05-15 20:00:00
Further research is needed into the pathological mechanisms and long-term outcomes of the neurologic manifestations of babesiosis.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Non-Small Cell Lung Cancer
3004986
us
1
0.5
9
0.5
0.5
Roundtable
0
1
General Surgery2023-05-03 20:00:00
The complexity of treatment has increased dramatically; how effectively are you communicating with your patients?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Acute Leukemia
5005273
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-04-30 20:00:00
Do you understand the role of non-targetable driver mutations in the management of acute myeloid leukemia (AML)?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Biologic Therapy
5000033
global
1
0.75
9
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-04-27 20:00:00
How much do you know about antibody-drug conjugates (ADCs) for solid tumor management?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Non-Small Cell Lung Cancer
3004986
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-04-27 20:00:00
KRAS G12C-mutated NSCLC: do you know best practices for patient care?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Lung Cancer
5000186
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-04-23 20:00:00
Do you know how to personalize care for lung cancer patients with EGFR exon 20 mutations?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Lung Cancer
5000186
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-04-23 20:00:00
Sharpen your identification and treatment of patients with lung cancer.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Melanoma
65
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-04-20 20:00:00
Are you up to date on the use of lymphocyte-activation gene 3 (LAG3) inhibitors to treat patients with metastatic melanoma?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Chronic Lymphocytic Leukemia
1551
global
1
0.25
9
0.25
0.25
Roundtable
0
1
Hematology-Oncology2023-04-11 20:00:00
Did you know studies have shown that noncovalent BTK inhibitors are efficacious in patients with covalent BTK inhibitor-pretreated CLL?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Lung Cancer
5000186
global
1
0.75
9
0.75
2
0.75
3
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-03-30 20:00:00
Increase your clinical acumen with these engaging presentations on NSCLC.
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Lung Cancer
5000186
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-30 20:00:00
Hear the most recent and impactful developments for lung cancer care in this captivating series.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Non-Small Cell Lung Cancer
3004986
global
1
0.75
9
0.75
2
0.75
3
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-03-30 20:00:00
Find out about new and exciting innovations in targeted therapies from these informative presentations.
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Small Cell Lung Cancer
275
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-30 20:00:00
Hear about pioneering efforts to address the challenges of small cell lung cancer care in these immersive presentations.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Non-Small Cell Lung Cancer
3004986
global
1
1.0
9
1.0
2
1.0
3
1.0
1.0
Roundtable
0
1
Hematology-Oncology2023-03-30 20:00:00
Do you know the latest information on targeted therapies for mNSCLC?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Hepatocellular Carcinoma
3032322
global
1
1.25
9
1.25
1.25
Clinical Review
0
2
Hematology-Oncology2023-03-30 20:00:00
How do you manage your patients with cholangiocarcinoma?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Non-Small Cell Lung Cancer
3004986
global
1
1.25
9
1.25
2
1.25
3
1.25
1.25
Roundtable
0
1
Hematology-Oncology2023-03-29 20:00:00
Eager to learn more about managing small cell lung cancer (SCLC)? Get ready with these cutting-edge talks.
1.25ABIM MOC
1.25CME/CE
75MIN
Save
